Morphotek® (www.morphotek.com) is a biotechnology company focused on the development of antibody-based therapies. In oncology, we are developing biological therapies that target underlying disease pathways and can overcome the immunosuppressive effects by tumors on immune-mediated experimental therapies… Read More
OcellO is an innovative biotech company offering services for drug discovery and early drug development. OcellO excels in clinically relevant in vitro 3D tumoroid assays, using Patient-derived xenograft (PDX) models and primary tumor cells (‘in vitro clinical trials’). We are experienced in working with…
Piramal Healthcare’s Antibody Drug Conjugate Business is one of the world’s leading contract development and manufacturing teams delivering early phase clinical and late phase commercial supplies. Our flexible manufacturing regime and dedication to ADC processing is why our clients choose Piramal Healthcare as their preferred partner. We seek to reduce the complexity associated with ADC processing allowing for integrated and seamless scale-up of each unique ADC program.
ProJect Pharmaceutics resourcefully develops tailored pharmaceutical formulations and lyophilization processes for biologics including ADCs and other highly potent drugs. Plying innovative predictive analytical methods and high-end freeze drying technology in our safety laboratories equipped with cutting edge technology enables us to deliver formulations and manufacturing processes on a sound scientific rationale pursuant ICH Q8 and other guidelines.